Is cancer a disease that can be cured? An answer based on a new classification of diseases
Peter Richmond, Bertrand M. Roehner

TL;DR
This paper proposes a new two-dimensional classification of diseases based on mortality age trends, suggesting that cancer is a mixed case closer to degenerative diseases, and discusses implications for curing diseases and human lifespan.
Contribution
It introduces a novel disease classification framework based on mortality curve asymmetry, providing insights into disease nature and implications for cure strategies.
Findings
Cancer is classified as a mixed disease, closer to degenerative diseases.
A new disease classification based on mortality trend asymmetry.
Effective cures for old-age diseases may not extend lifespan due to other unavoidable causes.
Abstract
Is cancer a disease that can be cured or a degenerative disease which comes predominantly with old age? We give an answer based on a two-dimensional representation of diseases. These two dimensions are defined as follows. In mortality curves there is an age, namely a_c = 10 years, which plays a crucial role in the sense that the mortality rate decreases in the interval I1=(a<a_c) and increases in the interval I2=(a>a_c). The respective trends in I1 and I2 are the two parameters used in our classification of diseases. Within the framework of reliability analysis, I1 and I2 would be referred to as the "burn-in" and "wear-out" phases. This leads to define three broad groups of diseases. (AS1) Asymmetry with prevalence of I1. (AS2) Asymmetry with prevalence of I2. (S) Symmetry, with I1 and I2 both playing roles of comparable importance. Not surprisingly, among AS1-cases one finds all…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFrailty in Older Adults · Health Systems, Economic Evaluations, Quality of Life · Chronic Disease Management Strategies
